Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury

Study:

A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)

Rationale:

n/a

Purpose:

The purpose of this protocol is to evaluate the safety of a selective cytopheretic device (SCD) in patients that are on continuous renal replacement therapy (CRRT) for acute kidney injury (AKI).

Study Status: Recruiting

Recruiting:
Michelle Garcia 216-444-7753 GARCIAM1@ccf.org

Condition Intervention Phase
Acute Kidney Injury Device: SCD Phase 2

Verified by CytoPherx, Inc January, 2013

Sponsored by: CytoPherx, Inc
Information provided by: CytoPherx, Inc
ClinicalTrials.gov identifier: NCT01400893

Study Type: Interventional

Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Cleveland Clinic
Cleveland, Ohio 44195
United States

n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.